Advanced respiratory monitoring to help safer ventilation in ICU patients without respiratory failure
Official title: Advanced Respiratory Monitoring for Safer Mechanical Ventilation in Patients Without Respiratory Failure
Run by Istituto Clinico Humanitas · NCT07686315 · Data updated 2026-11-12
This study tests whether using advanced respiratory monitoring in adults who are intubated for reasons other than respiratory failure can help prevent ARDS.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Istituto Clinico Humanitas Academic / other |
| Locations | 1 site (Milan, Lombardy) |
| Status | Recruiting |
| Started | June 30, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07686315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who are invasively ventilated for non-respiratory reasons (e.g., coma, trauma, sepsis) and begin monitoring within 24 hours of intubation at a participating center.
✕Probably not a fit
Patients who do not develop ARDS or who do not experience changes in ventilation strategy based on monitoring may see no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll adults 18 and older who are invasively ventilated for conditions such as coma, trauma, or sepsis. Monitoring includes continuous airway and esophageal pressure, flow measurements, and lung ventilation distribution to tailor ventilation settings. The goal is to see if applying these monitoring techniques in patients without initial respiratory failure can reduce the risk of developing ARDS and related complications. Data from this single-site initiative at Humanitas Research Hospital will help determine feasibility and potential impact on ventilator strategy. The study does not assign a treatment but observes outcomes associated with enhanced monitoring practices.
Why it matters
Potential benefit: If successful, enhanced monitoring could help clinicians personalize ventilation to reduce ARDS risk and improve outcomes for ICU patients on mechanical ventilation.
How similar studies have gone: Prior use of advanced respiratory monitoring in ARDS has shown benefits; applying these techniques in non-respiratory failure patients is investigational with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Study Population Eligibility Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Inclusion Criteria: Adult patients +18 years. Undergoing invasive mechanical ventilation for reasons other than acute respiratory failure (such as coma, trauma, or sepsis). Initiation of monitoring within 24 hours of oro-tracheal intubation. Exclusion Criteria: Evidence of pneumothorax, pneumomediastinum, or subcutaneous emphysema. Pregnancy. Absolute contraindications to nasogastric tube placement. Absolute contraindications to electrical impedance tomography (EIT) monitoring.
Where it's running
-
Humanitas Research Hospital
Milan, Lombardy, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Full-Course ECMO Pathway for Moderate-to-Severe ARDS
This study tests a standardized, full-course ECMO management pathway to see if it improves care for adults with moderate-to-severe ARDS treated with VV-ECMO in real-world Chinese centers.
-
Height measurement methods to guide ventilator settings in ARDS
We’re testing whether more precise height measurements change how researchers set lung-protective tidal volumes in adults with ARDS who are on a ventilator.
-
Corticosteroids for a hyperinflammatory state in critical illness
This trial tests whether methylprednisolone helps improve organ function and survival in adults with sepsis or ARDS who show a hyperinflammatory profile.
-
Right‑heart function and heart–lung interaction during ARDS with mechanical ventilation
This project will follow adults with ARDS on mechanical ventilation to see how positive‑pressure breathing affects the right heart over time and how that relates to circulation.
-
Umbilical‑cord mesenchymal stem cell and secretome therapy for severe ARDS
This trial tests whether IV umbilical‑cord mesenchymal stem cells, alone or with secretome, help adults with severe ARDS recover lung function and reduce inflammation.
-
Human umbilical cord mesenchymal stem cell injection for moderate to severe ARDS
This will test whether a single injection of human umbilical cord mesenchymal stem cells can help adults with moderate to severe ARDS that hasn't improved after standard treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.